Full Press Release Details
Courtney Dugan joined Immuneering in December 2025 as Vice President, Head of Investor Relations and Corporate Communications. She brings 18 years of experience in investor relations, financial communications, corporate positioning, and reputation management across the healthcare industry. She previously served as Vice President, Head of Investor Relations and Corporate Affairs at Y-mAbs Therapeutics from May 2023 to November 2025, following the company’s acquisition by SERB Pharmaceuticals. Earlier, Ms. Dugan led the investor relations and corporate communications functions at Olema Oncology and Pyxis Oncology. From April 2020 to November 2021, Ms. Dugan served as Senior Director of Global Finance Communications at Johnson & Johnson, where she led strategic purpose-driven initiatives aimed at enhancing the company’s corporate perception among key external audiences. Prior to Johnson & Johnson, she held leadership roles of increasing responsibility at key investor relations and financial communications agencies – including Real Chemistry, Syneos Health and ICR, Inc. – serving clients across the biotech, pharmaceutical and life sciences industries. Ms. Dugan received a B.A. in Corporate Communications and Public Affairs from Southern Methodist University and an M.B.A from Columbia Business School.